1998
DOI: 10.1164/ajrccm.157.6.9706036
|View full text |Cite
|
Sign up to set email alerts
|

Improvement of Cystic Fibrosis Airway Mucus Transportability by Recombinant Human DNase Is Related to Changes in Phospholipid Profile

Abstract: The aim of this study was to test whether changes in mucus surface properties by rhDNase treatment could be related to an increased recovery of phospholipids. Purulent sputa from 18 patients with cystic fibrosis (CF) were incubated with either rhDNase (4 microg/ml) or control excipient. The incubation of mucus samples with rhDNase induced a significant increase (p < 0.002) in the sol phase proportion (33.7 +/- 24.0%) compared with that obtained with excipient (12.6 +/- 12.4%). Phospholipids were recovered in s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
17
0
3

Year Published

2000
2000
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(22 citation statements)
references
References 23 publications
2
17
0
3
Order By: Relevance
“…C, the steady state viscosity of CF sputum at shear rates 10 Ϫ2 Ϫ10 2 rad/s. Physiological rates in the normal lung are 0.2-0.9 rad/s (24). Inset, viscosities of individual CF sputum samples at physiological shear rates.…”
Section: Resultsmentioning
confidence: 99%
“…C, the steady state viscosity of CF sputum at shear rates 10 Ϫ2 Ϫ10 2 rad/s. Physiological rates in the normal lung are 0.2-0.9 rad/s (24). Inset, viscosities of individual CF sputum samples at physiological shear rates.…”
Section: Resultsmentioning
confidence: 99%
“…Equally relevant, but a conceptually novel finding is the downregulation of DNase I, with a potential loss of capacity to break down luminal DNA, which could again increase mucus viscosity. It is notable that DNase I is used therapeutically to reduce mucus viscosity in cystic fibrosis cases by reducing the DNA content (70).…”
Section: Discussionmentioning
confidence: 99%
“…DNA is more widely distributed throughout purulent CF sputum samples than Ps. aeruginosa-derived alginate (Mrsny et al 1996); both recombinant human DNase (Zahm et al 1998) and alginate lyase (Mrsny et al 1994) reduce the viscosity and improve the surface properties of CF sputum, leading to speculation that aerosol delivery of such enzymes prior to chest percussion and postural drainage in severely affected CF patients could aid clearance of adhesive mucus from the airways. An alginate lyase from Bacillus circulans degraded the mucoid exopolysaccharide from the surface of CF isolates of Ps.…”
Section: Introductionmentioning
confidence: 99%